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ABSTRACT | Patients with Fibromyalgia syndrome 
(FMS) report higher ratings of perceived exertion (RPE) 
compared to healthy individuals for the same exercise 
intensity; however, to our knowledge, no studies have 
evaluated RPE at the ventilatory anaerobic threshold 
(VAT) for this population. This study aimed to assess RPE 
using the Borg CR-10 scale during a cardiopulmonary 
exercise test (CPET) in women with FMS. Twenty-four 
women with FMS and twenty healthy control subjects 
(HC) voluntarily participated in this study. Near the end 
of every 1-minute period during CPET, subjects were 
asked to report their RPE for fatigue in the lower limbs 
(RPE-L) and dyspnea (RPE-D), respectively, according 
to the Borg CR-10 scale. FMS subjects showed higher 
RPE-L and RPE-D compared to HC subjects at free 
wheel and at the first load increment. However, no 
significant difference was observed between groups 
for power output. There was no significant difference 
between groups for RPE-L and RPE-D reported at VAT 
and peak CPET. However, FMS subjects showed lower 
power output compared to HC subjects. The present 
results showed that FMS subjects present higher RPE 
compared to HC subjects. However, RPE reported 
at VAT and at peak CPET was not different between 
groups. The Borg CR-10 scale scores obtained at VAT 
can be used as an additional parameter for prescribing 
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exercise intensity in aerobic training protocols for 
women with FMS.
Keywords | Pain; Physical Fitness; Physical Exertion; 
Fibromyalgia.
RESUMO | Pacientes com síndrome fibromiálgica 
(SFM) relatam elevados níveis de percepção subjetiva 
de esforço (PSE) em comparação com indivíduos 
saudáveis para a mesma intensidade de exercício; no 
entanto, a nosso conhecimento, nenhum estudo avaliou 
a PSE no limiar de anaerobiose ventilatório (LAV) para 
essa população. Este estudo buscou avaliar PSE usando 
a escala CR-10 de Borg durante um teste de exercício 
cardiopulmonar (TECP) em mulheres com SFM. Vinte e 
quatro mulheres com SFM e vinte indivíduos saudáveis 
(GS) participaram deste estudo voluntariamente. Perto 
do final de cada período de 1 minuto durante CPET, os 
indivíduos foram convidados a relatar sua PSE para 
fadiga nos membros inferiores (PSE-MMII) e dispneia 
(PSE-D), respectivamente, de acordo com a escala CR-
10 de Borg. Os indivíduos com SFM mostraram maior 
PSE-MMII e PSE-D, em comparação com indivíduos 
GS tanto na carga livre como no primeiro incremento 
de carga. No entanto, não houve diferença significativa 
entre os grupos para a potência e nem para PSE-
MMII e PSE-D relatado no LAV e no pico TECP. No 
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entanto, indivíduos com SFM mostraram baixa potência em 
comparação com indivíduos GS. Esses resultados mostraram 
que indivíduos com SFM apresentam a PSE mais elevada em 
comparação com indivíduos GS. No entanto, a PSE relatada 
no LAV e no pico TECP não foi diferente entre os grupos. As 
pontuações de escala CR-10 de Borg obtidas no LAV podem 
ser usadas como um parâmetro adicional para a prescrição 
da intensidade de exercício nos protocolos de treinamento 
aeróbio para mulheres com SFM.
Descritores | Dor; Aptidão Física; Physical Exertion; Fibromialgia.
RESUMEN | Los pacientes con síndrome de fibromialgia (FMS) 
reportan índices más altos de esfuerzo percibido (RPE) en 
comparación con individuos sanos para la misma intensidad de 
ejercicio; sin embargo, a nuestro conocimiento, ningún estudio 
ha evaluado el RPE en el umbral ventilatorio anaeróbico (VAT) 
para estas personas. Este estudio tuvo como objetivo evaluar el 
RPE utilizando la escala Borg CR-10 durante un test de ejercicio 
cardiopulmonar (CPET) en mujeres con FMS. Veinticuatro 
mujeres con FMS y veinte individuos de control sanos (HC) 
participaron voluntariamente en este estudio. Cerca del final 
de cada período de 1 minuto durante el CPET, se pidió a los 
individuos que informaran su RPE para la fatiga en los miembros 
inferiores (RPE-L) y disnea (RPE-D), respectivamente, según la 
escala Borg CR-10. Los individuos con FMS mostraron mayores 
RPE-L y RPE-D comparados con los individuos HC en la rueda 
libre y en el primer incremento de carga. Sin embargo, no se 
observó diferencia significativa de potencia de salida entre los 
grupos. No hubo diferencias significativas entre los grupos en 
los RPE-L y RPE-D reportados en el VAT y en el máximo CPET. 
No obstante, los individuos FMS mostraron una menor potencia 
en comparación con los individuos HC. Los resultados actuales 
mostraron que los individuos con FMS presentan RPE más alto 
en comparación con los individuos HC. De todos modos, el RPE 
reportado en el VAT y en el CPET máximo no fue diferente entre 
los grupos. Las puntuaciones de la escala Borg CR-10 obtenidas 
en el VAT se pueden utilizarse como un parámetro adicional 
para prescribir la intensidad del ejercicio en protocolos de 
entrenamiento aeróbico para mujeres con FMS.
Palabras clave | Dolor; Aptitud Física; Esforço Físico; Fibromialgia.
INTRODUCTION
Fibromyalgia syndrome (FMS) is a non-
inflammatory rheumatic condition mainly characterized 
by widespread chronic pain1. In addition to pain, some 
authors suggest that these patients report higher 
ratings of perceived exertion (RPE) compared to 
healthy individuals for the same exercise intensity2. 
Thus, in combination with other common symptoms 
of FMS (e.g., pain, fatigue, joint stiffness, orthostatic 
intolerance)3,4, high RPE may contribute to low 
physical activity levels and low aerobic functional 
capacity observed in this population2,5-7.
Therefore, aerobic exercise has been recommended 
for the treatment of patients with FMS for its numerous 
benefits, such as reduced pain and increased aerobic 
functional capacity and better quality of life6. Moreover, 
according to Valim et al.5, low to moderate-intensity 
exercise should be prioritized instead of highintensity 
exercise, since the improvement of the aerobic functional 
capacity is not associated with improved symptoms. It 
is noteworthy that the ventilatory anaerobic threshold 
(VAT) better reflects the aerobic functional capacity 
of patients with FMS than the peak oxygen uptake 
(VO2peak), since these patients are usually not able to 
perform maximal exercise during cardiopulmonary 
exercise testing (CPET)5.
Therefore, VAT is an important parameter for the 
assessment and prescription of exercise intensity, since 
it provides a homogeneous acute metabolic response to 
physical training stimulus for different individuals, and 
does not expose patients to the risk of high-intensity 
exercises8.
In this sense, some authors have proposed the Borg 
CR-10 scale as a complementary tool to determine 
the workload related to VAT9-11. In addition, RPE has 
been used to prescribe exercise intensity, especially 
during non-supervised exercises, as it increases the 
accuracy and assertiveness in keeping the prescribed 
exercise intensity6,11,12. Therefore, determining RPE 
corresponding to VAT and determining if the RPE 
behavior during incremental exercise test in women 
with FMS differs from healthy individuals is relevant 
to improve the effectiveness of non-supervised exercises 
for this population.
Based on the above, this study aimed to test the 
hypothesis that women with FMS show higher RPE 
compared to healthy women for relative exercise 
intensity, but not at specific moments of CPET such as 
VAT and exercise peak.
Andrade et al. Borg CR-10 scale in women with FMS
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METHODOLOGY
Participants
The study included 24 subjects with clinical diagnosis 
of FMS according to criteria established by the American 
College of Rheumatology1. Twenty healthy subjects 
who matched the FMS group for age, body mass index 
(BMI) and physical activity level (IPAQ) composed the 
healthy control group (HC)13. Subjects who had history of 
cardiovascular, respiratory or metabolic disease of any kind, 
musculoskeletal abnormalities or inflammation as cause 
of pain, neurological disorder, smokers, or those engaged 
in regular physical activity were excluded from the study.
The study was approved by the Research Ethics 
Committee of the institution (Protocol 112 508) and 
all subjects signed the informed consent form.
Study protocol
All subjects were evaluated in the morning. The room 
temperature was maintained between 22°C and 24°C 
and relative humidity between 40% and 60%. Subjects 
were familiarized with the experimental protocol and 
instructed to have a light meal two hours before the 
experiment. Subjects were also advised to abstain from 
stimulants and alcoholic beverages 24 hours prior to 
the evaluation, and not to perform strenuous exercise 
48 hours before the experiment.
CPET
The CPET protocol was continuous ramp type 
performed in cycle ergometer with electromagnetic 
braking (Quinton Corival 400, Seattle, WA, USA) and 
with seat adjusted to allow about 5 to 10 degrees of 
knee flexion. Subjects were instructed to keep pedaling 
cadence at 60 revolutions per minute (rpm) and not to 
perform isometric contraction of upper limbs during 
the test.
CPET consisted of 1 minute at rest in the sitting 
position on the cycle ergometer, followed by 4 minutes 
of warm-up exercise at intensity of 4 W of power output 
(free wheel). Subsequently, power output increment 
protocol was initiated until physical exhaustion (exercise 
peak), defined as the time when subjects were unable 
to keep pedaling at 60 rpm or until the manifestation 
of a limiting symptom (e.g., pain, dizziness, nausea) or 
respiratory fatigue10.
Power output increments were determined for each 
subject according to formula proposed by Wasserman et 
al.14 Power (W) = ([(height ‒ age) .14] ‒ [150+(6 body . 
mass)])/100.
During CPET, electrocardiogram and heart rate 
(HR) were recorded beat by beat in real time using 
CardioPerfect® device (Welch Allyn CardioPerfect 
Workstation, Skaneateles Falls, NY).
At the end of CPET, three blinded experienced 
researchers determined VAT using the graphic visual 
method to estimate the disproportionate increase in 
ventilatory and metabolic variables during dynamic 
incremental exercise15. The criterion adopted was the 
loss of parallelism between VO2 and VCO215.
Recording ventilatory and metabolic variables
VO2, VCO2, VE, and respiratory exchange ratio 
(RER) were recorded on a breath-to-breath basis 
over CPET using an expired gas measurement system 
(Ultima PFX system, Medical Graphics, St. Paul, MN) 
calibrated before each test.
Borg CR-10 Scale
During familiarization session, each participant 
received instructions on the use of the Borg CR-10 scale 
including anchoring procedures16. Near the end of each 
1-minute period during CPET, participants were asked 
to report RPE for fatigue in the lower limbs (RPE-L) 
and for dyspnea (RPE-D), respectively, according to the 
Borg CR-10 scale16.
Statistical analysis
To assess data normality, the Shapiro-Wilk test was 
used. For continuous variables, intergroup comparison was 
performed using the Student t test for independent samples. 
For discontinuous variable “number of postmenopausal 
volunteers,” the χ2 test was performed. The significance 
level for both tests was set at 5%.
To compare RPE-L, RPE-D and power output 
between FMS and HC groups over CPET, 4 moments 
were analyzed: (1) free wheel (corresponding to the 
warm-up period of CPET); (2) first load increment 
(time that included the first minute after the start of the 
power increment); (3) VAT and (4) exercise peak. For 
the intergroup comparison at each of the 4 moments, 
the Mann-Whitney test was conducted. For intragroup 
Fisioter Pesqui. 2017;24(3):267-272
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comparison, the Friedman test was conducted. For both 
tests, a priori Bonferroni adjustment was performed, and 
p-values  < 0.01 were considered significant. All analyses 
were performed using the software BioEstat5.0®.
RESULTS
Clinical data of FMS and HC groups are shown 
in Table 1. FMS had higher BMI compared to HC 
(p<0.05). No significant differences were observed for 
the other variables (p>0.05).
Table 1. Age, anthropometric characteristics and baseline 
hemodynamic variables of fibromyalgia syndrome group (FMS) 
and healthy group (HC).
Variables HC (n = 20) FMS (n = 24) P
Age (years) 46 ± 7 49 ± 8 0.11
BMI (Kg∕m2) 24.7 ± 3.0 27.0 ± 3.9 0.006
N postmenopausal 
subjects 12 13 0.93
SBP (mmHg) 117 ± 12 117 ± 13 0.97
DBP (mmHg) 66 ± 7 69 ± 6 0.62
HR (bpm) 66 ± 8 71 ± 8 0.45
Data presented as mean ± standard deviation. N: number of volunteers; BMI: body mass index; 
SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate.
Table 2 shows the cardiorespiratory variables obtained 
at VAT and peak CPET. FMS group presented lower 
relative VO2 compared to HC group at VAT (p<0.05). At 
peak CPET, participants of FMS group presented lower 
HR, relative VO2, absolute VO2, VCO2 and VE (p<0.05).
Figure 1 shows RPE-L, RPE-D and power output 
obtained during CPET. FMS showed higher RPE-L 
and RPE-D compared to HC group at free wheel and 
at the first load increment (p<0.001). However, there 
was no significant difference between groups for power 
output (p>0.05).
At VAT and peak CPET, there was no significant 
difference between groups for RPE-L and RPE-D 
(p>0.05). However, FMS showed lower power output 
compared to HC (p<0.001).
Regarding intragroup comparisons, both groups 
showed progressive increases in RPE-L and RPE-D 
along CPET. In HC, RPE-L and RPE-D reported 
at VAT and at exercise peak were higher compared to 
RPE-L and RPE-D reported at free wheel (p<0.01) 
and first load increment (p<0.01). In FMS, RPE-L and 
RPE-D obtained at exercise peak were higher compared 
to values in situation with free wheel (p<0.01), first load 
increment (p<0.01) and at VAT (p<0.01). Moreover, 
RPE-L and RPE-D reported at VAT were higher 
compared to situation with free wheel (p<0.01).
Table 2. Cardiorespiratory and metabolic variables obtained 
at ventilatory anaerobic threshold (VAT) and peak of the 
cardiopulmonary exercise test of fibromyalgia syndrome (FMS) 
and healthy control groups (HC).
Variables HC (n = 20) FMS (n = 24) P
VAT
HR (bpm) 112 ± 15 105 ± 12 0.09
VO2 (mL.kg
-1.min-1) 12.1 ± 2.2 9.5 ± 2.8 < 0.001
VO2 (L.min
-1) 0.65 ± 0.30 0.65 ± 0.19 0.98
VCO2 (L.min
-1) 0.63 ± 0.20 0.63 ± 0.18 0.97
RER 0.97 ± 0.01 0.97 ± 0.02 0.81
VE (L.min-1) 21.8 ± 3.40 19.8 ± 5.70 0.14
PEAK
HR (bpm) 148 ± 12 131 ± 18 < 0.001
VO2 (mL.kg
-1.min-1) 19.0 ± 4.2 14.8 ± 3.6 < 0.001
VO2 (L.min
-1) 1.19 ± 0.20 1.00 ± 0.20 0.01
VCO2 (L.min
-1) 1.37 ± 0.30 1.15 ± 0.30 0.03
RER 1.17 ± 0.09 1.14 ± 0.13 0.38
VE (L.min-1) 43.8 ± 12.5 36.4 ± 12.0 0.05
Data presented as mean ± standard deviation. N: number of volunteers; VAT: ventilatory anae-
robic threshold; Peak: peak cardiopulmonary test; HR: heart rate; SBP: systolic blood pressure; 
DBP: diastolic blood pressure; VO2: oxygen uptake; VCO2: carbon dioxide production; RER: 
respiratory exchange ratio; VE: ventilation.
Figure 1. Ratings of perceived exertion for fatigue in the lower 
limbs (RPE-L) (a), dyspnea (RPE-D) (b) and power output (c) 
obtained at free wheel, first load increment, ventilatory anaerobic 
threshold (VAT) and peak of the cardiopulmonary exercise test.
Andrade et al. Borg CR-10 scale in women with FMS
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DISCUSSION
The main findings of this study showed that during 
CPET, RPE was higher in FMS group compared to 
HC group, both in situations with free wheel and in 
the first load increment. Moreover, RPE at VAT and 
exercise peak was not significantly different between 
groups. However, FMS presented smaller power output 
than HC at both moments (i.e., VAT and exercise peak).
Previous studies have reported that RPE in women 
with FMS is greater compared to healthy subjects 
during constant load testing2,17. The authors attribute 
this result to a possible overlap of the peripheral pain 
perception with the perceived exertion during exercise, 
increasing sensory stimuli from the musculoskeletal 
system and consequently RPE17.
Therefore, the amplification of sensory information 
from the musculoskeletal system during exercise may have 
hindered the discrimination of fatigue in lower limbs, 
dyspnea and pain sensation in the present study, resulting in 
increased RPE at free wheel and at the first load increment, 
since the power output was similar for both groups.
Another factor that may have contributed to this 
finding is possible different muscle recruitment in FMS 
group during exercise. Pierrynowski et al.18 observed 
during walking exercise that women with FMS use 
hip flexor muscles instead of plantar flexor muscles to 
enhance gait, which contributed to their perception of 
this activity as strenuous.
Interesting finding of this study was that although 
power output at VAT and exercise peak was different 
between groups, no significant differences between 
RPE-L and RPE-D were found. However, it has been 
shown that groups with different characteristics (e.g., 
male and female, active and sedentary, etc.) have similar 
RPE values  at certain times of the exercise such as VAT 
and exercise peak9-11. The authors reported that the fact 
that RPE at VAT does not vary among individuals with 
different characteristics enables its use as complementary 
tool for physical exercise prescription.
Studies on RPE in patients with FMS are relevant 
since the misinterpretation of physical exertion (i.e., 
high perceived exertion for relatively low exercise 
intensities) may contribute to low physical activity 
levels and lower aerobic functional capacity, commonly 
observed in these patients. In this study, the results 
showed that FMS showed lower  relative VO2, absolute 
VO2 and VCO2 values at peak CPET compared 
to healthy subjects. The impairment of the aerobic 
functional capacity in patients with FMS has been 
well documented in the literature2,5-7. Several factors 
may contribute to the low aerobic functional capacity 
in patients with FMS. Soriano-Maldonado et al.7 
found an association between pressure pain threshold 
and aerobic functional capacity, indicating that the 
higher the pressure pain threshold, the greater the 
individual’s ability to perform physical exercises. On 
the other hand, Valim et al.5 reported that in addition 
to sensory and metabolic dysfunction, the impairment 
of behavioral and cognitive functions should also be 
considered as potential factors that could contribute 
to the low aerobic functional capacity both at exercise 
peak and VAT.
VAT has been considered a physiological parameter 
internationally accepted for assessing the aerobic 
functional capacity and quantifying aerobic exercise 
intensity19. In addition, some authors have reported the 
importance of physical training at levels close to VAT8. 
Among the main advantages, the non-exposure of patients 
to the risks of high-intensity exercises, the lower risk 
of injuries and greater adherence to physical training 
protocols stand out. Moreover, VAT reflects better the 
aerobic functional capacity of patients with FMS than 
VO2max or VO2peak, since these patients are usually not able 
to perform maximal exercise during CPET5,6.
The lack of significant difference between groups for 
RPE at VAT and exercise peak suggests that RPE reflects 
the physiological responses to the increasing exercise 
intensity regardless of the absolute values of power output. 
RPE processing during physical activity results from the 
integration of multiple afferent signals of sensory receptors 
located in active skeletal muscles and cardiopulmonary 
system20. These structures can be stimulated by metabolic 
acidosis associated with decreased blood and muscular 
pH21. Thus, an increase in efferent neuromotor activity 
should occur to compensate for the peripheral fatigue 
resulting from contractile failure, which also modulates 
perceived exertion14. Thus, the higher the intensity of the 
effort, the greater the RPE.
Considering that the RPE-L and RPE-D values 
at specific physiological moments such as VAT and 
peak CPET were similar for both groups (FMS and 
HC), we suggest that RPE can be an additional and 
efficient parameter for prescribing physical training for 
this population. Thus, the use of the Borg CR-10 scale 
should be encouraged as an additional parameter to guide 
the practice of physical activity, especially non-supervised 
aerobic exercises in patients with FMS.
Fisioter Pesqui. 2017;24(3):267-272
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CONCLUSION
In conclusion, the results of this study showed that 
patients with FMS have higher RPE compared to 
healthy subjects. In addition, the Borg CR-10 scale 
scores obtained at VAT can be used as an additional 
parameter for prescribing exercise intensity in aerobic 
training protocols for women with FMS.
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